TreeWAS – Variant ID: rs1003582

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E03.9 Hypothyroidism, unspecified	1.000	0.000	0.000
K90.0 Coeliac disease	1.000	0.000	0.000
E83.1 Disorders of iron metabolism	1.000	0.000	0.000
E03 Other hypothyroidism	0.999	0.001	0.000
E05.9 Thyrotoxicosis, unspecified	0.999	0.001	0.000
E05 Thyrotoxicosis [hyperthyroidism]	0.999	0.001	0.000
E00-E07 Disorders of thyroid gland	0.998	0.002	0.000
E06 Thyroiditis	0.964	0.036	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.940	0.060	0.000
E06.3 Autoimmune thyroiditis	0.925	0.075	0.000
E83 Disorders of mineral metabolism	0.833	0.167	0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.828	0.172	0.000
E06.9 Thyroiditis, unspecified	0.779	0.221	0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.764	0.236	0.000
E83.4 Disorders of magnesium metabolism	0.725	0.275	0.000
E03.5 Myxoedema coma	0.716	0.284	0.000
E03.4 Atrophy of thyroid (acquired)	0.716	0.284	0.000
E03.3 Postinfectious hypothyroidism	0.716	0.284	0.000
E05.5 Thyroid crisis or storm	0.716	0.284	0.000
E05.4 Thyrotoxicosis factitia	0.716	0.284	0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.716	0.284	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.716	0.284	0.000
E00 Congenital iodine-deficiency syndrome	0.716	0.284	0.000
E06.5 Other chronic thyroiditis	0.704	0.296	0.000
E06.4 Drug-induced thyroiditis	0.691	0.309	0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.691	0.309	0.000
E06.1 Subacute thyroiditis	0.691	0.309	0.000
E06.0 Acute thyroiditis	0.691	0.309	0.000
E83.5 Disorders of calcium metabolism	0.663	0.337	0.000
E70-E90 Metabolic disorders	0.640	0.360	0.000
E03.8 Other specified hypothyroidism	0.637	0.363	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.629	0.371	0.000
E03.0 Congenital hypothyroidism with diffuse goitre	0.613	0.386	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.608	0.392	0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.605	0.395	0.000
E83.9 Disorder of mineral metabolism, unspecified	0.597	0.402	0.000
E83.8 Other disorders of mineral metabolism	0.597	0.402	0.000
E83.2 Disorders of zinc metabolism	0.597	0.402	0.000
E83.0 Disorders of copper metabolism	0.597	0.402	0.000
E89.0 Postprocedural hypothyroidism	0.584	0.416	0.000
E03.1 Congenital hypothyroidism without goitre	0.554	0.446	0.000
E84 Cystic fibrosis	0.517	0.483	0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.513	0.487	0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.513	0.487	0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.513	0.487	0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.513	0.487	0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.513	0.487	0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.513	0.487	0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.513	0.487	0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.513	0.487	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.513	0.487	0.000
K90 Intestinal malabsorption	0.511	0.489	0.000
E80 Disorders of porphyrin and bilirubin metabolism	0.506	0.494	0.000
E07 Other disorders of thyroid	0.490	0.510	0.000
E05.8 Other thyrotoxicosis	0.478	0.521	0.001
E86 Volume depletion	0.471	0.529	0.000
E40-E46 Malnutrition	0.465	0.535	0.000
E89.5 Postprocedural testicular hypofunction	0.463	0.537	0.000
E77 Disorders of glycoprotein metabolism	0.459	0.541	0.000
E76 Disorders of glycosaminoglycan metabolism	0.459	0.541	0.000
E72 Other disorders of amino-acid metabolism	0.459	0.541	0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.459	0.541	0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.459	0.541	0.000
E70 Disorders of aromatic amino-acid metabolism	0.451	0.549	0.000
E74 Other disorders of carbohydrate metabolism	0.450	0.550	0.000
E89.1 Postprocedural hypoinsulinaemia	0.445	0.555	0.000
E89.2 Postprocedural hypoparathyroidism	0.441	0.559	0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.434	0.566	0.000
E89.8 Other postprocedural endocrine and metabolic disorders	0.434	0.566	0.000
E84.9 Cystic fibrosis, unspecified	0.429	0.571	0.000
E89.4 Postprocedural ovarian failure	0.427	0.573	0.000
E80.1 Porphyria cutanea tarda	0.419	0.581	0.000
E89.3 Postprocedural hypopituitarism	0.418	0.582	0.000
E79 Disorders of purine and pyrimidine metabolism	0.414	0.586	0.000
E80.7 Disorder of bilirubin metabolism, unspecified	0.399	0.601	0.000
E80.2 Other porphyria	0.395	0.605	0.000
E83.3 Disorders of phosphorus metabolism	0.394	0.606	0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.390	0.610	0.000
E88 Other metabolic disorders	0.386	0.614	0.000
K90.8 Other intestinal malabsorption	0.382	0.618	0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.371	0.629	0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.371	0.629	0.000
E84.8 Cystic fibrosis with other manifestations	0.371	0.629	0.000
E84.1 Cystic fibrosis with intestinal manifestations	0.371	0.629	0.000
E84.0 Cystic fibrosis with pulmonary manifestations	0.371	0.629	0.000
K90.3 Pancreatic steatorrhoea	0.367	0.633	0.000
K90.2 Blind loop syndrome, not elsewhere classified	0.367	0.633	0.000
K90.1 Tropical sprue	0.367	0.633	0.000
K90.9 Intestinal malabsorption, unspecified	0.365	0.635	0.000
E80.5 Crigler-Najjar syndrome	0.363	0.637	0.000
E80.3 Defects of catalase and peroxydase	0.363	0.637	0.000
E80.0 Hereditary erythropoietic porphyria	0.363	0.637	0.000
E07.1 Dyshormogenetic goitre	0.351	0.648	0.000
E07.0 Hypersecretion of calcitonin	0.351	0.648	0.000
E80.6 Other disorders of bilirubin metabolism	0.350	0.649	0.000
E46 Unspecified protein-energy malnutrition	0.347	0.653	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.344	0.656	0.000
E73 Lactose intolerance	0.333	0.667	0.000
E44 Protein-energy malnutrition of moderate and mild degree	0.333	0.667	0.000
E45 Retarded development following protein-energy malnutrition	0.333	0.667	0.000
E43 Unspecified severe protein-energy malnutrition	0.333	0.667	0.000
E42 Marasmic kwashiorkor	0.333	0.667	0.000
E41 Nutritional marasmus	0.333	0.667	0.000
E40 Kwashiorkor	0.333	0.667	0.000
E74.0 Glycogen storage disease	0.330	0.670	0.000
E71.3 Disorders of fatty-acid metabolism	0.329	0.671	0.000
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified	0.329	0.671	0.000
E71.1 Other disorders of branched-chain amino-acid metabolism	0.329	0.671	0.000
E71.0 Maple-syrup-urine disease	0.329	0.671	0.000
E72.9 Disorder of amino-acid metabolism, unspecified	0.329	0.671	0.000
E72.8 Other specified disorders of amino-acid metabolism	0.329	0.671	0.000
E72.5 Disorders of glycine metabolism	0.329	0.671	0.000
E72.4 Disorders of ornithine metabolism	0.329	0.671	0.000
E72.3 Disorders of lysine and hydroxylysine metabolism	0.329	0.671	0.000
E72.2 Disorders of urea cycle metabolism	0.329	0.671	0.000
E72.1 Disorders of sulphur-bearing amino-acid metabolism	0.329	0.671	0.000
E72.0 Disorders of amino-acid transport	0.329	0.671	0.000
E76.9 Disorder of glucosaminoglycan metabolism, unspecified	0.329	0.671	0.000
E76.8 Other disorders of glucosaminoglycan metabolism	0.329	0.671	0.000
E76.3 Mucopolysaccharidosis, unspecified	0.329	0.671	0.000
E76.2 Other mucopolysaccharidoses	0.329	0.671	0.000
E76.1 Mucopolysaccharidosis, type II	0.329	0.671	0.000
E76.0 Mucopolysaccharidosis, type I	0.329	0.671	0.000
E77.9 Disorder of glycoprotein metabolism, unspecified	0.329	0.671	0.000
E77.8 Other disorders of glycoprotein metabolism	0.329	0.671	0.000
E77.1 Defects in glycoprotein degradation	0.329	0.671	0.000
E77.0 Defects in posttranslational modification of lysosomal enzymes	0.329	0.671	0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified	0.324	0.676	0.000
E70.8 Other disorders of aromatic amino-acid metabolism	0.324	0.676	0.000
E70.2 Disorders of tyrosine metabolism	0.324	0.676	0.000
E70.1 Other hyperphenylalaninaemias	0.324	0.676	0.000
E70.0 Classical phenylketonuria	0.324	0.676	0.000
E74.9 Disorder of carbohydrate metabolism, unspecified	0.323	0.677	0.000
E74.8 Other specified disorders of carbohydrate metabolism	0.323	0.677	0.000
E74.4 Disorders of pyruvate metabolism and gluconeogenesis	0.323	0.677	0.000
E74.2 Disorders of galactose metabolism	0.323	0.677	0.000
E74.1 Disorders of fructose metabolism	0.323	0.677	0.000
E88.8 Other specified metabolic disorders	0.318	0.681	0.000
E70.3 Albinism	0.316	0.684	0.000
E50-E64 Other nutritional deficiencies	0.312	0.688	0.000
E74.3 Other disorders of intestinal carbohydrate absorption	0.306	0.694	0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified	0.297	0.703	0.000
E79.8 Other disorders of purine and pyrimidine metabolism	0.297	0.703	0.000
E79.1 Lesch-Nyhan syndrome	0.297	0.703	0.000
E88.3 Tumour lysis syndrome	0.295	0.704	0.000
E07.8 Other specified disorders of thyroid	0.284	0.716	0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.280	0.720	0.000
E75.6 Lipid storage disorder, unspecified	0.266	0.734	0.000
E75.4 Neuronal ceroid lipofuscinosis	0.266	0.734	0.000
E75.3 Sphingolipidosis, unspecified	0.266	0.734	0.000
E75.1 Other gangliosidosis	0.266	0.734	0.000
E75.0 GM2 gangliosidosis	0.266	0.734	0.000
E80.4 Gilbert's syndrome	0.256	0.744	0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease	0.251	0.749	0.000
E88.9 Metabolic disorder, unspecified	0.249	0.751	0.000
E15 Nondiabetic hypoglycaemic coma	0.246	0.753	0.000
E07.9 Disorder of thyroid, unspecified	0.245	0.755	0.000
E75.2 Other sphingolipidosis	0.241	0.759	0.000
E73.8 Other lactose intolerance	0.239	0.761	0.000
E73.1 Secondary lactase deficiency	0.239	0.761	0.000
E73.0 Congenital lactase deficiency	0.239	0.761	0.000
E44.1 Mild protein-energy malnutrition	0.239	0.761	0.000
E44.0 Moderate protein-energy malnutrition	0.239	0.761	0.000
E63 Other nutritional deficiencies	0.235	0.765	0.000
E58 Dietary calcium deficiency	0.228	0.772	0.000
E56 Other vitamin deficiencies	0.227	0.772	0.000
E64 Sequelae of malnutrition and other nutritional deficiencies	0.224	0.776	0.000
E50 Vitamin A deficiency	0.224	0.776	0.000
E60 Dietary zinc deficiency	0.224	0.776	0.000
E59 Dietary selenium deficiency	0.224	0.776	0.000
E54 Ascorbic acid deficiency	0.224	0.776	0.000
E52 Niacin deficiency [pellagra]	0.224	0.776	0.000
N42.8 Other specified disorders of prostate	0.000	0.778	0.222
E88.1 Lipodystrophy, not elsewhere classified	0.220	0.780	0.000
E51 Thiamine deficiency	0.220	0.780	0.000
E75.5 Other lipid storage disorders	0.215	0.784	0.001
E55 Vitamin D deficiency	0.215	0.784	0.000
E65-E68 Obesity and other hyperalimentation	0.206	0.794	0.000
N42 Other disorders of prostate	0.000	0.798	0.202
E88.2 Lipomatosis, not elsewhere classified	0.192	0.807	0.000
N42.1 Congestion and haemorrhage of prostate	0.000	0.810	0.190
N42.2 Atrophy of prostate	0.000	0.811	0.189
E85 Amyloidosis	0.185	0.814	0.001
E63.9 Nutritional deficiency, unspecified	0.179	0.821	0.000
E61 Deficiency of other nutrient elements	0.179	0.821	0.000
E63.8 Other specified nutritional deficiencies	0.168	0.831	0.000
E63.1 Imbalance of constituents of food intake	0.168	0.831	0.000
E63.0 Essential fatty acid [EFA] deficiency	0.168	0.831	0.000
E04 Other non-toxic goitre	0.168	0.832	0.000
E56.1 Deficiency of vitamin K	0.167	0.833	0.000
E56.9 Vitamin deficiency, unspecified	0.163	0.837	0.000
E56.8 Deficiency of other vitamins	0.163	0.837	0.000
E56.0 Deficiency of vitamin E	0.163	0.837	0.000
E50.9 Vitamin A deficiency, unspecified	0.161	0.839	0.000
E50.8 Other manifestations of vitamin A deficiency	0.161	0.839	0.000
E50.7 Other ocular manifestations of vitamin A deficiency	0.161	0.839	0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea	0.161	0.839	0.000
E50.5 Vitamin A deficiency with night blindness	0.161	0.839	0.000
E50.4 Vitamin A deficiency with keratomalacia	0.161	0.839	0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis	0.161	0.839	0.000
E50.2 Vitamin A deficiency with corneal xerosis	0.161	0.839	0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis	0.161	0.839	0.000
E50.0 Vitamin A deficiency with conjunctival xerosis	0.161	0.839	0.000
E64.9 Sequelae of unspecified nutritional deficiency	0.161	0.839	0.000
E64.8 Sequelae of other nutritional deficiencies	0.161	0.839	0.000
E64.3 Sequelae of rickets	0.161	0.839	0.000
E64.2 Sequelae of vitamin C deficiency	0.161	0.839	0.000
E64.1 Sequelae of vitamin A deficiency	0.161	0.839	0.000
E64.0 Sequelae of protein-energy malnutrition	0.161	0.839	0.000
E51.9 Thiamine deficiency, unspecified	0.158	0.842	0.000
E51.8 Other manifestations of thiamine deficiency	0.158	0.842	0.000
E51.1 Beriberi	0.158	0.842	0.000
L30.9 Dermatitis, unspecified	0.157	0.843	0.000
I84.6 Residual haemorrhoidal skin tags	0.156	0.844	0.000
E55.0 Rickets, active	0.155	0.845	0.000
E51.2 Wernicke's encephalopathy	0.153	0.846	0.000
E53 Deficiency of other B group vitamins	0.150	0.850	0.000
E67 Other hyperalimentation	0.148	0.852	0.000
E68 Sequelae of hyperalimentation	0.148	0.852	0.000
E55.9 Vitamin D deficiency, unspecified	0.146	0.854	0.000
E04.0 Non-toxic diffuse goitre	0.142	0.858	0.000
E16 Other disorders of pancreatic internal secretion	0.139	0.861	0.000
N42.3 Dysplasia of prostate	0.000	0.863	0.137
N42.9 Disorder of prostate, unspecified	0.000	0.866	0.134
E85.2 Heredofamilial amyloidosis, unspecified	0.133	0.867	0.001
E85.1 Neuropathic heredofamilial amyloidosis	0.133	0.867	0.001
E85.0 Nonneuropathic heredofamilial amyloidosis	0.133	0.867	0.001
N42.0 Calculus of prostate	0.000	0.870	0.130
E61.9 Deficiency of nutrient element, unspecified	0.128	0.871	0.000
E61.8 Deficiency of other specified nutrient elements	0.128	0.871	0.000
E61.7 Deficiency of multiple nutrient elements	0.128	0.871	0.000
E61.6 Vanadium deficiency	0.128	0.871	0.000
E61.5 Molybdenum deficiency	0.128	0.871	0.000
E61.4 Chromium deficiency	0.128	0.871	0.000
E61.3 Manganese deficiency	0.128	0.871	0.000
E61.0 Copper deficiency	0.128	0.871	0.000
E61.2 Magnesium deficiency	0.124	0.876	0.000
E04.8 Other specified non-toxic goitre	0.121	0.879	0.000
E16.0 Drug-induced hypoglycaemia without coma	0.116	0.884	0.000
E85.8 Other amyloidosis	0.113	0.886	0.001
E78 Disorders of lipoprotein metabolism and other lipidaemias	0.114	0.886	0.000
E73.9 Lactose intolerance, unspecified	0.113	0.886	0.001
E65 Localised adiposity	0.108	0.892	0.000
E53.1 Pyridoxine deficiency	0.107	0.892	0.000
E53.0 Riboflavin deficiency	0.107	0.892	0.000
E85.3 Secondary systemic amyloidosis	0.106	0.893	0.001
E67.8 Other specified hyperalimentation	0.106	0.893	0.000
E67.3 Hypervitaminosis D	0.106	0.893	0.000
E67.2 Megavitamin-B6 syndrome	0.106	0.893	0.000
E67.1 Hypercarotenaemia	0.106	0.893	0.000
E67.0 Hypervitaminosis A	0.106	0.893	0.000
E16.9 Disorder of pancreatic internal secretion, unspecified	0.100	0.900	0.000
E16.8 Other specified disorders of pancreatic internal secretion	0.100	0.900	0.000
E16.4 Abnormal secretion of gastrin	0.100	0.900	0.000
E16.3 Increased secretion of glucagon	0.100	0.900	0.000
E78.8 Other disorders of lipoprotein metabolism	0.099	0.901	0.000
E85.9 Amyloidosis, unspecified	0.097	0.902	0.001
E53.9 Vitamin B deficiency, unspecified	0.095	0.905	0.000
E85.4 Organ-limited amyloidosis	0.091	0.908	0.001
E61.1 Iron deficiency	0.091	0.908	0.000
E78.9 Disorder of lipoprotein metabolism, unspecified	0.086	0.914	0.000
E78.6 Lipoprotein deficiency	0.085	0.914	0.000
E78.3 Hyperchylomicronaemia	0.082	0.918	0.000
E78.1 Pure hyperglyceridaemia	0.081	0.919	0.000
E78.4 Other hyperlipidaemia	0.074	0.925	0.000
L30 Other dermatitis	0.065	0.935	0.000
E16.1 Other hypoglycaemia	0.062	0.937	0.001
E53.8 Deficiency of other specified B group vitamins	0.060	0.940	0.000
L30.0 Nummular dermatitis	0.052	0.948	0.000
L30.3 Infective dermatitis	0.049	0.950	0.000
L30.5 Pityriasis alba	0.047	0.953	0.000
L30.2 Cutaneous autosensitisation	0.047	0.953	0.000
E78.2 Mixed hyperlipidaemia	0.047	0.953	0.000
K90-K93 Other diseases of the digestive system	0.046	0.954	0.000
E10-E14 Diabetes mellitus	0.045	0.955	0.000
L30.1 Dyshidrosis [pompholyx]	0.044	0.956	0.000
L30.4 Erythema intertrigo	0.044	0.956	0.000
E04.1 Non-toxic single thyroid nodule	0.041	0.959	0.000
L30.8 Other specified dermatitis	0.040	0.960	0.000
E04.2 Non-toxic multinodular goitre	0.034	0.966	0.000
K93 Disorders of other digestive organs in diseases classified elsewhere	0.033	0.966	0.000
I77.1 Stricture of artery	0.034	0.966	0.000
I77 Other disorders of arteries and arterioles	0.033	0.967	0.000
E12 Malnutrition-related diabetes mellitus	0.033	0.967	0.000
N40-N51 Diseases of male genital organs	0.000	0.968	0.032
I78.1 Naevus, nonneoplastic	0.032	0.968	0.000
I70-I79 Diseases of arteries, arterioles and capillaries	0.032	0.968	0.000
I78 Diseases of capillaries	0.032	0.968	0.000
N43 Hydrocele and spermatocele	0.000	0.969	0.031
N43.3 Hydrocele, unspecified	0.000	0.969	0.031
I74 Arterial embolism and thrombosis	0.030	0.970	0.000
I77.6 Arteritis, unspecified	0.030	0.970	0.000
I71 Aortic aneurysm and dissection	0.030	0.970	0.000
N40 Hyperplasia of prostate	0.000	0.970	0.030
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.029	0.971	0.000
I74.2 Embolism and thrombosis of arteries of the upper extremities	0.029	0.971	0.000
I77.2 Rupture of artery	0.029	0.971	0.000
K75 Other inflammatory liver diseases	0.028	0.972	0.000
K70-K77 Diseases of liver	0.028	0.972	0.000
K75.4 Autoimmune hepatitis	0.027	0.973	0.000
E14 Unspecified diabetes mellitus	0.027	0.973	0.000
E66 Obesity	0.027	0.973	0.000
K72 Hepatic failure, not elsewhere classified	0.027	0.973	0.000
K72.9 Hepatic failure, unspecified	0.027	0.973	0.000
I78.8 Other diseases of capillaries	0.026	0.974	0.000
K74 Fibrosis and cirrhosis of liver	0.026	0.974	0.000
I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture	0.026	0.974	0.000
I74.4 Embolism and thrombosis of arteries of extremities, unspecified	0.026	0.974	0.000
I79 Disorders of arteries, arterioles and capillaries in diseases classified elsewhere	0.026	0.974	0.000
K75.8 Other specified inflammatory liver diseases	0.026	0.974	0.000
E04.9 Non-toxic goitre, unspecified	0.025	0.974	0.000
I70 Atherosclerosis	0.025	0.975	0.000
N44 Torsion of testis	0.000	0.975	0.025
I74.1 Embolism and thrombosis of other and unspecified parts of aorta	0.025	0.975	0.000
K70 Alcoholic liver disease	0.024	0.976	0.000
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere	0.024	0.976	0.000
K93.1 Megacolon in Chagas' disease	0.024	0.976	0.000
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands	0.024	0.976	0.000
I71.3 Abdominal aortic aneurysm, ruptured	0.024	0.976	0.000
I77.5 Necrosis of artery	0.024	0.976	0.000
I77.4 Coeliac artery compression syndrome	0.024	0.976	0.000
I77.3 Arterial fibromuscular dysplasia	0.024	0.976	0.000
I77.0 Arteriovenous fistula, acquired	0.024	0.976	0.000
I71.1 Thoracic aortic aneurysm, ruptured	0.024	0.976	0.000
K73 Chronic hepatitis, not elsewhere classified	0.024	0.976	0.000
E12.9 Without complications	0.023	0.976	0.000
E12.8 With unspecified complications	0.023	0.976	0.000
E12.7 With multiple complications	0.023	0.976	0.000
E12.6 With other specified complications	0.023	0.976	0.000
E12.5 With peripheral circulatory complications	0.023	0.976	0.000
E12.4 With neurological complications	0.023	0.976	0.000
E12.3 With ophthalmic complications	0.023	0.976	0.000
E12.2 With renal complications	0.023	0.976	0.000
E12.1 With ketoacidosis	0.023	0.976	0.000
E12.0 With coma	0.023	0.976	0.000
E14.8 With unspecified complications	0.024	0.976	0.000
K70.1 Alcoholic hepatitis	0.024	0.976	0.000
E20-E35 Disorders of other endocrine glands	0.022	0.977	0.001
K75.9 Inflammatory liver disease, unspecified	0.023	0.977	0.000
E14.3 With ophthalmic complications	0.023	0.977	0.000
S72.10 Pertrochanteric fracture (closed)	0.000	0.977	0.023
I74.0 Embolism and thrombosis of abdominal aorta	0.023	0.977	0.000
N43.1 Infected hydrocele	0.000	0.977	0.023
I78.9 Disease of capillaries, unspecified	0.023	0.977	0.000
N43.4 Spermatocele	0.000	0.977	0.023
K74.6 Other and unspecified cirrhosis of liver	0.023	0.977	0.000
I74.8 Embolism and thrombosis of other arteries	0.023	0.977	0.000
N43.2 Other hydrocele	0.000	0.977	0.023
N43.0 Encysted hydrocele	0.000	0.977	0.022
N51 Disorders of male genital organs in diseases classified elsewhere	0.000	0.978	0.022
I79.2 Peripheral angiopathy in diseases classified elsewhere	0.022	0.978	0.000
I71.8 Aortic aneurysm of unspecified site, ruptured	0.022	0.978	0.000
I71.5 Thoracoabdominal aortic aneurysm, ruptured	0.022	0.978	0.000
K74.3 Primary biliary cirrhosis	0.022	0.978	0.000
I71.0 Dissection of aorta [any part]	0.022	0.978	0.000
K76.6 Portal hypertension	0.022	0.978	0.000
E14.2 Withrenal complications	0.022	0.978	0.000
K74.1 Hepatic sclerosis	0.021	0.978	0.000
I70.8 Atherosclerosis of other arteries	0.021	0.978	0.000
I74.9 Embolism and thrombosis of unspecified artery	0.021	0.979	0.000
E13 Other specified diabetes mellitus	0.021	0.979	0.000
K73.9 Chronic hepatitis, unspecified	0.021	0.979	0.000
N49 Inflammatory disorders of male genital organs, not elsewhere classified	0.000	0.979	0.021
I74.5 Embolism and thrombosis of iliac artery	0.021	0.979	0.000
E27.1 Primary adrenocortical insufficiency	0.021	0.979	0.000
K75.2 Nonspecific reactive hepatitis	0.020	0.979	0.000
K75.1 Phlebitis of portal vein	0.020	0.979	0.000
I77.8 Other specified disorders of arteries and arterioles	0.020	0.979	0.000
K77 Liver disorders in diseases classified elsewhere	0.020	0.979	0.000
K74.5 Biliary cirrhosis, unspecified	0.020	0.980	0.000
E27 Other disorders of adrenal gland	0.019	0.980	0.001
K71 Toxic liver disease	0.020	0.980	0.000
E14.7 With multiple complications	0.020	0.980	0.000
E14.0 With coma	0.020	0.980	0.000
N50 Other disorders of male genital organs	0.000	0.980	0.020
K70.0 Alcoholic fatty liver	0.020	0.980	0.000
E14.4 With neurological complications	0.020	0.980	0.000
S72.1 Pertrochanteric fracture	0.000	0.980	0.020
E66.1 Drug-induced obesity	0.019	0.980	0.000
N46 Male infertility	0.000	0.980	0.019
K70.9 Alcoholic liver disease, unspecified	0.020	0.980	0.000
S72.30 Fracture of shaft of femur (closed)	0.000	0.980	0.020
K72.1 Chronic hepatic failure	0.019	0.981	0.000
E14.6 With other specified complications	0.019	0.981	0.000
E66.2 Extreme obesity with alveolar hypoventilation	0.019	0.981	0.000
E14.1 With ketoacidosis	0.019	0.981	0.000
I70.1 Atherosclerosis of renal artery	0.019	0.981	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.019	0.981	0.000
K74.4 Secondary biliary cirrhosis	0.019	0.981	0.000
K74.2 Hepatic fibrosis with hepatic sclerosis	0.019	0.981	0.000
I70.80 Atherosclerosis of other arteries (without gangrene)	0.019	0.981	0.000
N41 Inflammatory diseases of prostate	0.000	0.981	0.019
I79.1 Aortitis in diseases classified elsewhere	0.018	0.981	0.000
I79.0 Aneurysm of aorta in diseases classified elsewhere	0.018	0.981	0.000
I78.0 Hereditary haemorrhagic telangiectasia	0.019	0.981	0.000
E31 Polyglandular dysfunction	0.018	0.981	0.001
K73.2 Chronic active hepatitis, not elsewhere classified	0.018	0.981	0.000
S72.3 Fracture of shaft of femur	0.000	0.981	0.019
N50.9 Disorder of male genital organs, unspecified	0.000	0.982	0.018
I70.0 Atherosclerosis of aorta	0.018	0.982	0.000
I70.9 Generalised and unspecified atherosclerosis	0.018	0.982	0.000
N45 Orchitis and epididymitis	0.000	0.982	0.018
K91 Postprocedural disorders of digestive system, not elsewhere classified	0.018	0.982	0.000
K76 Other diseases of liver	0.018	0.982	0.000
I70.2 Atherosclerosis of arteries of the extremities	0.018	0.982	0.000
C18.0 Caecum	0.018	0.982	0.000
E20 Hypoparathyroidism	0.016	0.983	0.001
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.017	0.983	0.000
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.017	0.983	0.000
S72 Fracture of femur	0.000	0.983	0.017
K70.2 Alcoholic fibrosis and sclerosis of liver	0.017	0.983	0.000
K72.0 Acute and subacute hepatic failure	0.017	0.983	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.016	0.983	0.001
E32 Diseases of thymus	0.016	0.983	0.001
E30 Disorders of puberty, not elsewhere classified	0.016	0.983	0.001
I71.9 Aortic aneurysm of unspecified site, without mention of rupture	0.017	0.983	0.000
I79.8 Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere	0.017	0.983	0.000
E25 Adrenogenital disorders	0.015	0.984	0.001
N51.8 Other disorders of male genital organs in diseases classified elsewhere	0.000	0.984	0.016
N51.1 Disorders of testis and epididymis in diseases classified elsewhere	0.000	0.984	0.016
N51.0 Disorders of prostate in diseases classified elsewhere	0.000	0.984	0.016
K91.9 Postprocedural disorder of digestive system, unspecified	0.016	0.984	0.000
N49.8 Inflammatory disorders of other specified male genital organs	0.000	0.984	0.016
I70.81 Atherosclerosis of other arteries (with gangrene)	0.015	0.984	0.000
E13.8 With unspecified complications	0.015	0.984	0.000
E13.7 With multiple complications	0.015	0.984	0.000
E13.6 With other specified complications	0.015	0.984	0.000
E13.5 With peripheral circulatory complications	0.015	0.984	0.000
E13.4 With neurological complications	0.015	0.984	0.000
E13.2 With renal complications	0.015	0.984	0.000
E13.1 With ketoacidosis	0.015	0.984	0.000
E13.0 With coma	0.015	0.984	0.000
C18 Malignant neoplasm of colon	0.016	0.984	0.000
E27.2 Addisonian crisis	0.015	0.984	0.000
K71.0 Toxic liver disease with cholestasis	0.015	0.985	0.000
K75.0 Abscess of liver	0.015	0.985	0.000
N49.9 Inflammatory disorder of unspecified male genital organ	0.000	0.985	0.015
N49.0 Inflammatory disorders of seminal vesicle	0.000	0.985	0.015
I77.9 Disorder of arteries and arterioles, unspecified	0.015	0.985	0.000
N51.2 Balanitis in diseases classified elsewhere	0.000	0.985	0.015
S72.31 Fracture of shaft of femur (open)	0.000	0.985	0.015
E31.0 Autoimmune polyglandular failure	0.015	0.985	0.001
K70.4 Alcoholic hepatic failure	0.015	0.985	0.000
K77.8 Liver disorders in other diseases classified elsewhere	0.015	0.985	0.000
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.015	0.985	0.000
K73.8 Other chronic hepatitis, not elsewhere classified	0.015	0.985	0.000
N41.8 Other inflammatory diseases of prostate	0.000	0.985	0.015
E27.3 Drug-induced adrenocortical insufficiency	0.014	0.985	0.001
E13.3 With ophthalmic complications	0.014	0.985	0.000
C18.3 Hepatic flexure	0.015	0.985	0.000
N50.1 Vascular disorders of male genital organs	0.000	0.985	0.015
E27.5 Adrenomedullary hyperfunction	0.014	0.985	0.001
E27.0 Other adrenocortical overactivity	0.014	0.985	0.001
K71.9 Toxic liver disease, unspecified	0.014	0.985	0.000
K71.8 Toxic liver disease with other disorders of liver	0.014	0.985	0.000
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.014	0.985	0.000
K71.5 Toxic liver disease with chronic active hepatitis	0.014	0.985	0.000
K71.4 Toxic liver disease with chronic lobular hepatitis	0.014	0.985	0.000
K71.3 Toxic liver disease with chronic persistent hepatitis	0.014	0.985	0.000
K71.2 Toxic liver disease with acute hepatitis	0.014	0.985	0.000
N41.9 Inflammatory disease of prostate, unspecified	0.000	0.985	0.015
I70.10 Atherosclerosis of renal artery (without gangrene)	0.014	0.985	0.000
N49.1 Inflammatory disorders of spermatic cord, tunica vaginalis and vas deferens	0.000	0.986	0.014
K91.5 Postcholecystectomy syndrome	0.014	0.986	0.000
S72.11 Pertrochanteric fracture (open)	0.000	0.986	0.014
K74.0 Hepatic fibrosis	0.014	0.986	0.000
K71.1 Toxic liver disease with hepatic necrosis	0.014	0.986	0.000
C18.4 Transverse colon	0.014	0.986	0.000
E66.0 Obesity due to excess calories	0.014	0.986	0.000
S72.9 Fracture of femur, part unspecified	0.000	0.986	0.014
N41.2 Abscess of prostate	0.000	0.986	0.014
I70.11 Atherosclerosis of renal artery (with gangrene)	0.014	0.986	0.000
E26 Hyperaldosteronism	0.013	0.986	0.001
S72.2 Subtrochanteric fracture	0.000	0.986	0.014
E14.5 With peripheral circulatory complications	0.013	0.986	0.000
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.014	0.986	0.000
Z42.1 Follow-up care involving plastic surgery of breast	0.000	0.986	0.014
C18.5 Splenic flexure	0.014	0.986	0.000
N41.3 Prostatocystitis	0.000	0.986	0.014
E31.9 Polyglandular dysfunction, unspecified	0.013	0.986	0.001
E31.8 Other polyglandular dysfunction	0.013	0.986	0.001
E31.1 Polyglandular hyperfunction	0.013	0.986	0.001
N49.2 Inflammatory disorders of scrotum	0.000	0.986	0.014
E34 Other endocrine disorders	0.013	0.986	0.001
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.013	0.987	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.013	0.987	0.000
I70.01 Atherosclerosis of aorta (with gangrene)	0.013	0.987	0.000
C18.2 Ascending colon	0.013	0.987	0.000
E20.9 Hypoparathyroidism, unspecified	0.012	0.987	0.001
I70.91 Generalized and unspecified atherosclerosis (with gangrene)	0.013	0.987	0.000
K76.5 Hepatic veno-occlusive disease	0.013	0.987	0.000
K76.4 Peliosis hepatis	0.013	0.987	0.000
K76.3 Infarction of liver	0.013	0.987	0.000
K76.2 Central haemorrhagic necrosis of liver	0.013	0.987	0.000
I70.00 Atherosclerosis of aorta (without gangrene)	0.013	0.987	0.000
K91.1 Postgastric surgery syndromes	0.013	0.987	0.000
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.000	0.987	0.013
E20.8 Other hypoparathyroidism	0.012	0.987	0.001
E20.1 Pseudohypoparathyroidism	0.012	0.987	0.001
E20.0 Idiopathic hypoparathyroidism	0.012	0.987	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations